Virios Therapeutics LLC [NASDAQ: VIRI] traded at a high on 05/18/21, posting a 19.37 gain after which it closed the day’ session at $5.67. The company report on May 18, 2021 that VIRI: Initiating Coverage of Virios Therapeutics; Attacking the Root Cause of Chronic Disease….
By David Bautz, PhD.
The results of the trading session contributed to over 4190055 shares changing hands. Over the past one week, the price volatility of Virios Therapeutics LLC stands at 10.17% while the volatility over the past one month is 7.01%.
The market cap for VIRI stock reached $46.38 million, with 9.72 million shares outstanding and 6.18 million shares in the current float. Compared to the average trading volume of 66.03K shares, VIRI reached a trading volume of 4190055 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Virios Therapeutics LLC [VIRI]?
The Average True Range (ATR) for Virios Therapeutics LLC is set at 0.38 The Price to Book ratio for the last quarter was 1.84, with the Price to Cash per share for the same quarter was set at 3.64.
How has VIRI stock performed recently?
Virios Therapeutics LLC [VIRI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.95.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VIRI stock in for the last two-week period is set at 57.80, with the RSI for the last a single of trading hit 67.09, and the three-weeks RSI is set at 51.26 for Virios Therapeutics LLC [VIRI]. The present Moving Average for the last 50 days of trading for this stock 5.58, while it was recorded at 4.95 for the last single week of trading.
Virios Therapeutics LLC [VIRI]: Deeper insight into the fundamentals
Return on Total Capital for VIRI is now -69.88, given the latest momentum, and Return on Invested Capital for the company is -129.66. Return on Equity for this stock declined to -167.93, with Return on Assets sitting at -65.09.
Reflecting on the efficiency of the workforce at the company, Virios Therapeutics LLC [VIRI] managed to generate an average of -$3,448,798 per employee.Virios Therapeutics LLC’s liquidity data is similarly interesting compelling, with a Quick Ratio of 20.50 and a Current Ratio set at 20.50.
Insider trade positions for Virios Therapeutics LLC [VIRI]
There are presently around $5 million, or 7.60% of VIRI stock, in the hands of institutional investors. The top three institutional holders of VIRI stocks are: MASTERS CAPITAL MANAGEMENT LLC with ownership of 600,000, which is approximately 33.941% of the company’s market cap and around 10.80% of the total institutional ownership; TWO SIGMA INVESTMENTS, LP, holding 107,334 shares of the stock with an approximate value of $0.61 million in VIRI stocks shares; and PVG ASSET MANAGEMENT CORP, currently with $0.31 million in VIRI stock with ownership of nearly New of the company’s market capitalization.
Positions in Virios Therapeutics LLC stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 14 institutional holders increased their position in Virios Therapeutics LLC [NASDAQ:VIRI] by around 448,071 shares. Additionally, 5 investors decreased positions by around 100,494 shares, while 0 investors held positions by with 369,581 shares. The mentioned changes placed institutional holdings at 918,146 shares, according to the latest SEC report filing. VIRI stock had 11 new institutional investments in for a total of 290,684 shares, while 4 institutional investors sold positions of 100,052 shares during the same period.